report_lead_image_with_gradient.png
Q3 2025

Healthtech VC Trends

Download this Report
To download this report, please complete the form below

PitchBook clients can access the complete Excel data pack via the Research Center on the PitchBook Platform.

Healthtech’s rebound gains traction as valuations rise amid an AI-driven growth cycle

Healthtech startups raised $3.9 billion in Q3 2025, marking a sustained recovery as deal volume rose 12% and investors doubled down on later-stage, AI-enabled platforms. The median VC pre-money valuation climbed to a record of $38.5 million, reflecting rising valuations—even as deal activity and valuations remain below their 2021 peak. These trends signal renewed momentum in healthtech VC after two years of uneven funding activity.

VC exit count hit an all-time high of 42 in the quarter, reflecting greater liquidity for smaller startups even as IPO activity paused. With more than $1.2 billion in venture funding to date, RCM remains one of healthtech’s most investable AI subsectors as provider and payer automation enters a new “bot-versus-bot” phase. Meanwhile, a growing roster of late-stage healthtech names, including Zocdoc, Spring Health, and Ro, are positioned for potential 2026 listings.


Table of contents
Healthtech landscape 3
Healthtech VC ecosystem market map 4
Quarterly analysis 5
Key takeaways 5
VC activity 5
AI themes 6
Healthtech VC deal summary 15